A Pilot Study to Investigate the Safety and Immunologic Activity AGS-004 an Autologous HIV Immunotherapeutic Agent.
This study has been completed.
Sponsor:
McGill University Health Center
Collaborators:
Université de Montréal
Argos Therapeutics
Information provided by:
McGill University Health Center
ClinicalTrials.gov Identifier:
NCT00381212
First received: September 25, 2006
Last updated: January 28, 2009
Last verified: January 2009
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | November 2008 |
| Primary Completion Date: | February 2008 (Final data collection date for primary outcome measure) |